Taken together, these sequential experiments demonstrate that lactate inhibition in the SCLC leads to decreased Nur77 expression in naïve CD8+T cells, reduces TCR tonic signaling, and subsequently enhances T cell activation and effector function. The gene discussed is CD8A; the disease is small cell lung carcinoma.